Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6661 AL 6675

Ginkgo biloba in Alzheimer's disease: a systematic review

Janssen IM, Sturtz S, Skipka G, Zentner A, Velasco Garrido M, Busse R.

Wien Med Wochenschr. 2010 Dec;160(21-22):539-46. doi: 10.1007/s10354-010-0844-8.

Atorvastatin and Aβ(1-40): not as simple as cholesterol reduction in brain and relevance to Alzheimer disease

Butterfield DA.

Exp Neurol. 2011 Mar;228(1):15-8. doi: 10.1016/j.expneurol.2010.12.014. Epub 2010 Dec 28.

Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action

Barone E, Cenini G, Di Domenico F, Martin S, Sultana R, Mancuso C, Murphy MP, Head E, Butterfield DA.

Pharmacol Res. 2011 Mar;63(3):172-80. doi: 10.1016/j.phrs.2010.12.007. Epub 2010 Dec 27.

Endothelin receptor antagonists: potential in Alzheimer's disease

Palmer J, Love S.

Pharmacol Res. 2011 Jun;63(6):525-31. doi: 10.1016/j.phrs.2010.12.008. Epub 2010 Dec 27.

Fixing Alzheimer disease trials by improving process and methods

Schneider LS.

Curr Alzheimer Res. 2010 Nov;7(7):564-5. doi: 10.2174/156720510793498995.

Neuroprotective role for galanin in Alzheimer's disease

Counts SE, Perez SE, Ginsberg SD, Mufson EJ.

Exp Suppl. 2010;102:143-62. doi: 10.1007/978-3-0346-0228-0_11.

Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease

Isik AT, Bozoglu E, Naharci MI, Kilic S.

Am J Geriatr Pharmacother. 2010 Oct;8(5):454-9. doi: 10.1016/j.amjopharm.2010.09.001.

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45. doi: 10.1002/gps.2638. Epub 2010 Oct 29.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384.

Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables

Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ.

J Alzheimers Dis. 2010;19(2):665-72. doi: 10.3233/JAD-2010-1269.

Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence

Szekely CA, Zandi PP.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):132-9. doi: 10.2174/187152710791012026.

Current treatment options for people with Alzheimer's disease in Croatia

Mimica N, Presecki P.

Chem Biol Interact. 2010 Sep 6;187(1-3):409-10. doi: 10.1016/j.cbi.2010.03.029. Epub 2010 Mar 20.

Drugs for Alzheimer's disease

Cranwell-Bruce LA.

Medsurg Nurs. 2010 Jan-Feb;19(1):51-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias